Compare GSK plc (GSK) vs Cloudflare Inc (NET) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Cloudflare Inc — how do they compare? GSK plc trades at $46.47 (market cap $91.88B), while Cloudflare Inc trades at $356.12 (market cap $121.74B). The key difference: Cloudflare Inc is the larger of the two by market cap, and GSK plc pays a 3.9% dividend while Cloudflare Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold GSK plc for 93 Days and Cloudflare Inc for 61 Days on average.
| GSK | NET | |
|---|---|---|
Market Cap | $91.88B | $121.74B |
Volume | 7,730,529 | 2,433,002 |
Sector | Health | Technology |
52-Week High | $61.18 | $359.60 |
52-Week Low | $43.24 | $160.16 |
Typical Hold Time | 93 Days | 61 Days |
Enterprise Value | $111.88B | $121.11B |
Dividend Yield | 3.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $47.02, up 0.9% with a P/E of 14.89, trading below industry averages. The stock shows strong profitability with 72.73% gross margins and 29.73% ROE, though technical indicators signal bearish momentum. Recent earnings beats and strategic oncology investments highlight growth potential amid patent cliff concerns.
GSK's valuation appears attractive with earnings momentum, but faces headwinds from technical weakness and HIV patent expirations. The bullish analyst sentiment (31% buy ratings) and pipeline innovation provide upside, while cost-saving initiatives and dividend yield offer stability. Key risks include competitive pressures and execution on £40B sales targets.
Cloudflare (NET) trades at $357.03, up 4.15% today, approaching its 52-week high. The stock shows strong technical momentum with bullish moving averages and recent earnings beats. Revenue growth remains robust at $2.17B for 2025, though profitability challenges persist with a -8.21% net margin. Recent product launches including Cloudflare Basin and strategic partnerships with Deutsche Telekom highlight ongoing innovation.
While analyst consensus remains strongly bullish (71% buy ratings), the stock trades above consensus targets at premium valuations (P/S 47.88). Key risks include persistent unprofitability and high valuation multiples. The company's growth trajectory and AI security positioning offer upside potential, but investors face volatility from execution risks and competitive pressures in the cloud infrastructure space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Cloudflare Inc
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
Read more on NET →
